Journal
DIABETES
Volume 65, Issue 7, Pages 1996-2005Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db15-1605
Keywords
-
Categories
Funding
- National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL115122]
- American Diabetes Association [1-10-BS-124]
- American Heart Association [13GRNT16080003]
Ask authors/readers for more resources
Modest elevations in C-reactive protein (CRP) are associated with type 2 diabetes. We previously revealed in mice that increased CRP causes insulin resistance and mice globally deficient in the CRP receptor Fc gamma receptor IIB (Fc gamma RIIB) were protected from the disorder. Fc gamma RIIB is expressed in numerous cell types including endothelium and B lymphocytes. Here we investigated how endothelial Fc gamma RIIB influences glucose homeostasis, using mice with elevated CRP expressing or lacking endothelial Fc gamma RIIB. Whereas increased CRP caused insulin resistance in mice expressing endothelial Fc gamma RIIB, mice deficient in the endothelial receptor were protected. The insulin resistance with endothelial Fc gamma RIIB activation was due to impaired skeletal muscle glucose uptake caused by attenuated insulin delivery, and it was associated with blunted endothelial nitric oxide synthase (eNOS) activation in skeletal muscle. In culture, CRP suppressed endothelial cell insulin transcytosis via Fc gamma RIIB activation and eNOS antagonism. Furthermore, in knock-in mice harboring constitutively active eNOS, elevated CRP did not invoke insulin resistance. Collectively these findings reveal that by inhibiting eNOS, endothelial Fc gamma RIIB activation by CRP blunts insulin delivery to skeletal muscle to cause insulin resistance. Thus, a series of mechanisms in endothelium that impairs insulin movement has been identified that may contribute to type 2 diabetes pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available